Related Experiment Video
Updated: Oct 8, 2025
09:57
Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
9.9K
Monocyte chemoattractant protein-1 and hypertension: An overview
1Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Hipertension Y Riesgo Vascular
|December 31, 2021
Summary
Monocyte chemoattractant protein-1 (MCP-1) is linked to hypertension and cardiovascular disease progression. Higher MCP-1 levels correlate with target organ damage and comorbidities, showing its potential in cardiovascular risk stratification.
Area of Science:
- Cardiovascular Medicine
- Inflammation Biology
- Biomarker Research
Background:
- Hypertension is increasingly linked to cardiovascular disease (CVD) via inflammatory biomarkers.
- Monocyte chemoattractant protein-1 (MCP-1) is a key chemokine in endothelial inflammation and atherosclerotic plaque development.
- MCP-1 attracts monocytes and macrophages, contributing to the inflammatory process in atherosclerosis.
Purpose of the Study:
- To review observational studies on serum MCP-1 levels in hypertensive patients.
- To investigate the relationship between MCP-1 and target organ damage (TOD) in hypertension.
- To explore MCP-1's role in cardiovascular risk stratification.
Main Methods:
- Systematic review of observational studies.
- Analysis of serum MCP-1 levels in hypertensive individuals.
- Correlation of MCP-1 with target organ damage and comorbidities.
Main Results:
- Elevated MCP-1 levels are associated with ongoing endothelial dysfunction and accumulated TOD.
- Observational studies clarify MCP-1's link to comorbidities like CKD, dyslipidemia, diabetes, and CAD.
- Medications for comorbidities may influence MCP-1 levels due to anti-inflammatory effects.
Conclusions:
- No universal normal MCP-1 threshold exists due to multifactorial influences (genetics, age, comorbidities, medications).
- MCP-1 shows promise as a tool for enhancing cardiovascular risk stratification.
- Prognostic studies confirm MCP-1's association with adverse cardiovascular outcomes, independent of other predictors.
Related Concept Videos
01:29Hypertension II: Pathophysiology
140
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
140
01:28Hypertension I: Introduction
136
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
136
01:18Hypertension and Regulation of Blood Pressure
3.3K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
01:18Neural Regulation of Blood Pressure
4.6K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
4.6K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
251
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
251
01:27Psychoneuroimmunology: Cardiovascular Disease
104
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
104